(Q36136151)

12 August 2017

Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group (English)

1 reference

12 August 2017

1 reference

1 reference

Kok TC

1

1 reference

12 August 2017

Van der Gaast A

2

1 reference

12 August 2017

Dees J

3

1 reference

12 August 2017

Eykenboom WM

4

1 reference

12 August 2017

Van Overhagen H

5

1 reference

12 August 2017

Stoter G

6

1 reference

12 August 2017

Tilanus HW

7

1 reference

12 August 2017

Splinter TA

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

6

1 reference

12 August 2017

980-984

1 reference

Contributions of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Etoposide and cisplatin in advanced esophageal cancer. A preliminary report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Surgical therapy of oesophageal carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Clinical pharmacology and schedule dependency of the podophyllotoxin derivatives

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

A phase II study of carboplatin in adenocarcinoma of the oesophagus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074745

cis-Dichlorodiammineplatinum(II) in the treatment of esophageal carcinoma

2 July 2018

1 reference

12 December 2020

Etoposide--chemistry, preclinical and clinical pharmacology

1 reference

12 December 2020

Phase II study of etoposide in the treatment of esophageal carcinoma

1 reference

12 December 2020

Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma

1 reference

12 December 2020

Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma

1 reference

12 December 2020

Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study

1 reference

12 December 2020

Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

1 reference

12 December 2020

Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage

1 reference

12 December 2020

Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide

1 reference

12 December 2020

Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial

1 reference

12 December 2020

Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial

1 reference

12 December 2020

Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer

1 reference

12 December 2020

Evaluation of response to preoperative chemotherapy in esophageal and gastric cardia cancer using biphasic esophagrams and surgical-pathologic correlation

1 reference

12 December 2020

A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer

1 reference

12 December 2020

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer

1 reference

12 December 2020

Carboplatin in the treatment of oesophageal cancer

1 reference

12 December 2020

Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy

1 reference

12 December 2020

Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung

1 reference

12 December 2020

Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.469

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8826870

1 reference